ISPOR - HT2 INFLUENCE OF HTA AND HOSPITAL FUNDING SYSTEMS ON PATIENT ACCESS TO INNOVATIVE MEDICINES- EXAMPLE OF ADVANCED RENAL CELL CANCER IN WESTERN EUROPE

Full Text

HT2 INFLUENCE OF HTA AND HOSPITAL FUNDING SYSTEMS ON PATIENT ACCESS TO INNOVATIVE MEDICINES- EXAMPLE OF ADVANCED RENAL CELL CANCER IN WESTERN EUROPE

Abstract

Authors

M Toumi J Misset S Jaroslawski S Aballea E Baynton M Lamure

Back to Volume 13, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now